
US court shuts down AstraZeneca's challenge to Medicare drug price plan
London: A federal appeals court on Thursday shut down AstraZeneca's challenge to the U.S. government's program that gives the Medicare health insurance plan the power to negotiate lower drug prices. The 3rd U.S. Circuit Court of Appeals upheld a …